INS and Hypoglycemia: The most immediate risk with intermittent fasting is the potential for hypoglycemia in patients who are on antidiabetic medications that are associated with hypoglycemia, specifically insulin (both prandial and basal) and sulfonylureas (including the short-acting meglitinides) [6,8,26].